503A Compounding Pharmacy

Deep dive

503A Compounding Pharmacy: complete reference

A 503A pharmacy (named for Section 503A of the Federal Food, Drug, and Cosmetic Act) is a traditional compounding pharmacy that prepares custom medications for individual patients based on specific prescriptions. State-licensed and primarily regulated by state Boards of Pharmacy with secondary FDA oversight, 503A pharmacies CAN compound medications that mirror or are similar to FDA-approved drugs ONLY when (a) there's a documented medical need not met by the FDA-approved version (e.g., allergy to inactive ingredient), or (b) the drug is on the FDA shortage list. 503A pharmacies CANNOT mass-produce or sell to other pharmacies/hospitals — they fill against per-patient prescriptions only. This was the primary legal pathway for compounded GLP-1 medications during the 2023-2024 semaglutide/tirzepatide shortage. Post-shortage-resolution, the legal basis for compounding popular medications narrowed substantially. Reputable 503A pharmacies often hold PCAB accreditation (voluntary quality standard from the Pharmacy Compounding Accreditation Board). To verify a 503A pharmacy is legitimate, check the state Board of Pharmacy license database (public lookup) and confirm sterile compounding certification.

In practice

A 503A pharmacy in Texas receives a prescription from your telehealth provider for compounded semaglutide, prepares your specific dose, and ships it to you — they cannot make extras to sell to other patients without prescriptions.

Clinical context

503A compounding remains legal for individual prescriptions. Mass production fell into legal grey area post-FDA-shortage-resolution.